Preterm Prelabor Rupture of Membranes: Outcomes with Expectant Management until 34 versus 35 Weeks.


Journal

American journal of perinatology
ISSN: 1098-8785
Titre abrégé: Am J Perinatol
Pays: United States
ID NLM: 8405212

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 16 12 2018
medline: 28 5 2020
entrez: 16 12 2018
Statut: ppublish

Résumé

To evaluate outcomes with expectant management of preterm prelabor rupture of membranes (PROM) until 35 weeks versus immediate delivery at ≥34 weeks. This was a multicenter retrospective cohort study of singletons with preterm PROM at >20 weeks from 2011 through 2017. Groups were defined as expectant management until 35 weeks versus immediate delivery at ≥34 weeks. Primary outcome was composite neonatal morbidity: need for respiratory support, culture positive neonatal sepsis, or antibiotic administration for >72 hours. Univariate and general estimating equation models were used with A total of 280 mother-infant dyads were included. There was no difference in composite neonatal outcome in pregnancies managed with expectant management compared with immediate delivery (43.4 vs. 37.5%; There is no difference in composite neonatal morbidity in pregnancies with preterm PROM managed with expectant management until 35 weeks as compared with immediate delivery at 34 weeks. Expectant management is associated with a decreased length of NICU admission but increased short-term infectious morbidity.

Identifiants

pubmed: 30553236
doi: 10.1055/s-0038-1675647
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

659-668

Informations de copyright

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Tara A Lynch (TA)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, New York.

Courtney Olson-Chen (C)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, New York.

Sarah Colihan (S)

Department of Obstetrics and Gynecology, Albany Medical Center, Albany, New York.

Jeffrey Meyers (J)

Department of Pediatrics, University of Rochester Medical Center, Rochester, New York.

Conisha Holloman (C)

Department of Obstetrics and Gynecology, Winnie Palmer Hospital for Women and Babies, Orlando Health, Orlando, Florida.

Dongmei Li (D)

Department of Clinical and Translational Research, University of Rochester, Rochester, New York.
Department of Obstetrics and Gynecology, Department of Public Health Sciences, University of Rochester, Rochester, New York.
Department of Public Health Sciences, University of Rochester, Rochester, New York.

Heather Link (H)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, New York.

Paola Torres (P)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas, Houston, Texas.

Annie Kim (A)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas, Houston, Texas.

Devon J King (DJ)

Department of Obstetrics and Gynecology, Albany Medical Center, Albany, New York.

Cari Eckman (C)

Albany Medical College, Albany, New York.

Anna Varlamov (A)

Department of Obstetrics and Gynecology, Winnie Palmer Hospital for Women and Babies, Orlando Health, Orlando, Florida.

Scott Dexter (S)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Albany Medical Center, Albany, New York.

Eva K Pressman (EK)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, New York.

Eleazar Soto-Torres (E)

Department of Clinical and Translational Research, University of Rochester, Rochester, New York.
Department of Obstetrics and Gynecology, Department of Public Health Sciences, University of Rochester, Rochester, New York.
Department of Public Health Sciences, University of Rochester, Rochester, New York.

Amol Malshe (A)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH